(2017) The Potential Role of Naltrexone in Borderline Personality Disorder. Iranian journal of psychiatry. pp. 142-146. ISSN 1735-4587 (Print) 1735-4587 (Linking)
Full text not available from this repository.
Abstract
Objective: Management of borderline personality disorder (BPD) is a difficult challenge due to the complex features of this disorder. This article reviews the use of naltrexone in the treatment of BPD. Method: Published articles and clinical trials were searched in Google Scholar, MedLine, ELSEVIER, and Cochrane database of systematic reviews abstracts in English language between 1990 and 2017. Results: Naltrexone (NTX), a nonspecific competitive opiate antagonist, has been noted to be helpful in controlling self-injurious behavior (SIB) and dissociative symptoms in patients with BPD. Conclusion: Further studies should be conducted on the effects of naltrexone to confirm the role of this medication in the treatment of BPD.
| Item Type: | Article |
|---|---|
| Keywords: | Borderline Personality Disorder Dissociative Symptoms Naltrexone Psychiatry and Psychology Category Self-Injurious Behavior |
| Divisions: | Faculty of Pharmacy and Pharmaceutical Sciences > Department of Clinical Pharmacy and Pharmacy Practice |
| Page Range: | pp. 142-146 |
| Journal or Publication Title: | Iranian journal of psychiatry |
| Journal Index: | Pubmed |
| Volume: | 12 |
| Number: | 2 |
| ISSN: | 1735-4587 (Print) 1735-4587 (Linking) |
| Depositing User: | مهندس مهدی شریفی |
| URI: | http://eprints.mui.ac.ir/id/eprint/1453 |
Actions (login required)
 |
View Item |